Covalent Radiopharmaceuticals
Covalent bonding radiopharmaceuticals have been developed in some studies, but they all have obvious deficiencies, mainly due to their high lipophilicity and non-specific covalent bonding. These fatal defects make them completely unable to be used for targeted radionuclide therapy.